• 1
    Stovall TG, Ling FW, Gray LA. Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 1991; 77: 754757.
  • 2
    Tanaka T, Hayashi H, Kutsuzawa T, Fujimoto S, Ichinoe K. Treatment of interstitial ectopic pregnancy with methotrexate report of a successful case. Fertil Steril 1982; 37: 851852.
  • 3
    Barnhart K, Mennuti MT, Benjamin I, Jacobson S, Goodman D, Coutifaris C. Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol 1994; 84: 10101015.
  • 4
    Tolaymat LL, Brown TL, Maher JE, Horan CA, Green BA, Ripps DA. Reproductive potential after methotrexate treatment of ectopic gestation in a community hospital. J Reprod Med 1999; 44: 335338.
  • 5
    Fernandez H, Gervaise A. Ectopic pregnancies after infertility treatment: modern diagnosis and therapeutic strategy. Hum Reprod 2004; 10: 503513.
  • 6
    Deloia JA, Stewart-Akers AM, Groinin MD. Effects of metho-trexate on trophoblast proliferation and local immune responses. Hum Reprod 1998; 13: 10631069.
  • 7
    Arnholdt H, Mcisci F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Archiv B Cell Pathol 1991; 60: 365372.
  • 8
    Longhi A, Pignotti E, Versari M, Asta S, Bacci G. Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma. Oncol Rep 2003; 10: 151155.
  • 9
    Lower EE, Blau R, Gazder P, Tummala R. The risk of premature menopause induced by chemotherapy for early breast cancer. J Womens Health Gend Based Med 1999; 8: 949954.
  • 10
    Bower M, Rustin GJ, Newlands ES, Holden L, Short D, Foskett M, Bagshawe KD. Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur J Cancer 1998; 34: 12041207.
  • 11
    Orvieto R, Kruchkovich J, Zohav E, Rabinson E, Anteby EY, Meltcer S. Does methotrexate treatment for ectopic pregnancy influence the patient's performance during asubsequent in vitro fertilization/embryo transfer cycle? Fertil Steril 2007; 88: 16851686.
  • 12
    Oriol B, Barrio A, Pacheco A, Serna J, Zuzuarregui JL, Garcia-Velasco JA. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Fertil Steril 2008; 90: 15791582.
  • 13
    McLaren JF, Burney RO, Milki AA, Westphal LM, Dahan MH, Lathi RB. Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation. Fertil Steril 2009; 92: 515519.
  • 14
    Fanchin R. Stimulation quality in IVF. J Gyn Obs Biol Reprod 2008; 37: S26S29.
  • 15
    Agostini A, Blanc K, Ronda I, Romain F, Capelle M, Blanc B. Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy. Fertil Steril 2007; 88: 504506.
  • 16
    Lipscomb GH, McCord ML, Stovall TG, Huff G, Portera SG, Ling FW. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 1999; 341: 19741978.
  • 17
    Stovall TG. Medical management should be routinely used as primary therapy for ectopic pregnancy. Clin Obstet Gynecol 1995; 38: 346352.
  • 18
    Lipscomb GH, Brand D, McCord ML, Portera JC, Ling FW. Analysis of three hundred fifteen ectopic pregnancies treated with single dose MTX. Am J Obstet Gynecol 1998; 178: 13541358.
  • 19
    Lipscomb GH, Givens VA, Meyer NL, Bran D. Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy. Fertil Steril 2004; 81: 12211224.
  • 20
    Gonen Y, Casper RF. Prediction of implantation by sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization. In Vitro Fert Embryo Transf 1990; 7: 146152.
  • 21
    Stovall TG, Ling FW, Buster JE. Reproductive performance after methotrexate treatment for ectopic pregnancy. Am J Obstet Gynecol 1990; 162: 16201623.
  • 22
    Pisarska MD, Caron SA, Buster JE. Ectopic pregnancy. Lancet 1998; 351: 11151120.
  • 23
    Gervaise A, Masson L, de Tayrac R, Frydman R, Fernandez H. Reproductive outcome after methotrexate treatment for tubal pregnancies. Fertil Steril 2004; 82: 304308.
  • 24
    Shapiro BS, Richter KS, Harris DC, Daneshmand ST. Influence of patient age on the growth and transfer of blastocyst-stage embryos. Fertil Steril 2004; 77: 700705.
  • 25
    Out HJ, Braat DD, Lintsen BM, Gurgan T, Bukulmez O, Gökmen O, Keles G, Cabarello P, Gonzalez JM, Fabreques F, Balash J, Roulier R. Increasing the daily dose of recombinantfollicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum Reprod 2000; 15: 2935.
  • 26
    Spandorfer SD, Avrech OM, Colombero LT, Palermo GD, Rosenwaks Z. Effect of paternal age on fertilization and pregnancy characteristics in couples treated by intracytoplasmic sperm injection. Hum Reprod 1998; 13: 334338.
  • 27
    Friedler S, Schencker J, Herman A, Lewin A. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod 1996; 2: 323335.
  • 28
    Welker BJ, Gembruch U, Diedrich K, Al-Hasani S, Krebs D. Transvaginal sonography of the endometrium during ovarian pick up in stimulated cycles for in vitro fertilization. J Ultrasound Med 1989; 8: 549553.
  • 29
    Dickey RP, Olar TT, Curole DN, Taylor SN, Rye PH. Endometrial pattern and thickness associated with pregnancy outcome after assisted reproduction technologies. Hum Reprod 1992; 7: 418421.